Empowered Funds
KPTI icon

Empowered Funds’s Karyopharm Therapeutics KPTI Stock Holding History

Empowered Funds’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$26.4K Buy
+21,610
New +$88.4K ﹤0.01% 2504

Other funds holding KPTI

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Empowered Funds's KPTI Position: Q3 2026 in Review

Empowered Funds opened a new position in Karyopharm Therapeutics (KPTI) in Q3 2026: 21,610 shares worth $26.4K. The stake represents ﹤0.01% of the portfolio and ranks #2504 among its holdings.

59 funds tracked by Wall St. Rank hold KPTI as of Q3 2026.

  • Empowered Funds held 21,610 shares of Karyopharm Therapeutics worth $26.4K as of Q3 2026.
  • Karyopharm Therapeutics was a new Empowered Funds position in Q3 2026.
  • Karyopharm Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2504 holding.
  • 59 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.